Monday, November 29

Pfizer succeeds in developing an edible treatment… Death and hospitalization rate 89%↓

Pfizer, the American pharmaceutical company that developed the coronavirus vaccine, announced that this time it has succeeded in making an edible treatment. It said that it had the effect of lowering the death and hospitalization rate by 89%, but the US government announced that it had already secured millions of cases.

Correspondent Kim Soo-hyung reports from Washington.

Pfizer announced today (the 6th) an antiviral drug ‘Paxrovid’, which is taken when contracted with Corona.

According to Pfizer, clinical trials have shown that taking this drug while infected can reduce hospitalization and mortality by 89%.

It is more effective than Merck’s molnupiravir, which has been shown to reduce hospitalization and mortality by 50%.

[앨버트 불라/화이자 CEO : 이 먹는 약은 수백만의 생명을 구하게 될 것입니다. 우리가 해법을 찾았고, 이제 정말 사용하기 좋은 때입니다. 이것은 코로나를 예방하는 것은 아니지만 불행하게도 코로나에 감염됐을 때 치료하는 것입니다.]

U.S. President Biden said he already has millions of doses of Pfizer’s oral coronavirus drug, ready to be used immediately if approved by health authorities.

[바이든/미국 대통령 : 우리는 이미 수백만 회 분량의 치료제를 확보했습니다. 치료제는 최악의 코로나로부터 사람들을 보호해줄 또 다른 도구가 될 것입니다.]

The best way to prevent coronavirus is with a coronavirus vaccine, health experts say.

However, as there are tens of millions of unvaccinated people in the United States alone, oral treatment is expected to make a significant contribution to minimizing the damage from the coronavirus.

Reference-news.sbs.co.kr

Leave a Reply

Your email address will not be published. Required fields are marked *